Moderna Inc (MRNA)
125.00
-0.59
(-0.47%)
USD |
NASDAQ |
May 03, 16:00
125.43
+0.43
(+0.34%)
After-Hours: 20:00
Moderna Gross Profit (TTM): 1.086B for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.086B |
| December 31, 2023 | 2.061B |
| September 30, 2023 | 3.408B |
| June 30, 2023 | 5.982B |
| March 31, 2023 | 9.582B |
| December 31, 2022 | 13.46B |
| September 30, 2022 | 16.22B |
| Date | Value |
|---|---|
| June 30, 2022 | 18.21B |
| March 31, 2022 | 18.49B |
| December 31, 2021 | 15.12B |
| September 30, 2021 | 9.343B |
| June 30, 2021 | 5.248B |
| March 31, 2021 | 1.812B |
| December 31, 2020 | 266.00M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
266.00M
Minimum
Dec 2020
18.49B
Maximum
Mar 2022
8.592B
Average
7.662B
Median
Gross Profit (TTM) Benchmarks
| Merck & Co Inc | 45.66B |
| Pfizer Inc | 31.64B |
| Eli Lilly and Co | 28.80B |
| Johnson & Johnson | 61.53B |
| Novavax Inc | 349.69M |